TAVR Versus SAVR in Aortic Stenosis: Long Journey, New Roadmap

Bernard D. Prendergast; Simon R. Redwood; Tiffany Patterson

doi:10.1016/j.jacc.2021.01.012

King's College London

King's main site

Research portal

TAVR Versus SAVR in Aortic Stenosis: Long Journey, New Roadmap

Research output: Contribution to journal › Editorial › peer-review

Bernard D. Prendergast, Simon R. Redwood, Tiffany Patterson

Original language	English
Pages (from-to)	1162-1164
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	77
Issue number	9
DOIs	https://doi.org/10.1016/j.jacc.2021.01.012
Published	9 Mar 2021
Additional links	Link to publication in Scopus

Bibliographical note

Funding Information: Prof. Prendergast has received unrestricted research and educational grants from Edwards Lifesciences; and has received speaker/consultancy fees from Abbott, Anteris, and Edwards Lifesciences. Prof. Redwood has served as a proctor for and received speaker fees from Edwards Lifesciences; and has served on the advisory board for Medtronic. Dr. Patterson has reported that she has no relationships relevant to the contents of this paper to disclose. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

View graph of relations

King's College London - Homepage

TAVR Versus SAVR in Aortic Stenosis: Long Journey, New Roadmap

Bibliographical note

King's Authors

By the same authors

With some of the same researchers

From the same journal